🔗 Share this article

Chancellor Rachel Reeves has stated she is planning "specific steps to address household expense challenges" in the upcoming financial statement.

During an interview with the BBC, she noted that lowering inflation is a collective responsibility of both the government and the central bank.

The UK's price growth is projected to be the highest among the G7 developed nations this year and next.

Potential Utility Bill Interventions

Reports indicate the government could intervene to reduce energy bills, for example by reducing the present 5% level of VAT applied on energy.

An additional possibility is to reduce some of the regulatory levies currently included in household expenses.

Fiscal Limitations and Expert Predictions

The government will receive the next assessment from the official forecaster, the Office for Budget Responsibility, on Monday, which will reveal how much space there is for these measures.

The consensus from most economists is that Reeves will have to announce higher taxes or expenditure reductions in order to fulfill her self-imposed fiscal targets.

Previously on Thursday, estimates indicated there was a £22 billion gap for the Treasury chief to fill, which is at the more modest range of forecasts.

"It is a shared task between the Bank of England and the administration to bear down further on some of the drivers of price increases," Reeves stated to the BBC in the US capital, at the conferences of the IMF and global financial institution.

Tax Commitments and International Concerns

While much of the attention has been on probable tax increases, the Treasury chief said the most recent information from the OBR had not changed her pledge to campaign commitments not to raise rates on income tax, VAT or social security contributions.

She blamed an "unpredictable world" with increasing international and commercial concerns for the Budget tax moves, likely to be directed on those "with the broadest shoulders."

International Trade Disputes

Commenting on concerns about the United Kingdom's trade ties with China she said: "The UK's security interests always take priority."

Last week's declaration by Chinese authorities to strengthen export controls on rare earths and other resources that are essential for high-technology manufacturing led American leader the US President to propose an extra 100% tariff on goods from the Asian country, raising the risk of an full-scale trade war between the two largest economies.

The American finance chief labeled China's move "economic coercion" and "a international production control attempt."

Inquired about considering the US offer to join its conflict with the Asian nation, the Chancellor said she was "extremely troubled" by China's measures and encouraged the Chinese government "not to put up barriers and restrict access."

She said the decision was "bad for the global economy and creates additional headwinds."

"It is my opinion there are sectors where we should confront Chinese policies, but there are also valuable prospects to export to Chinese markets, including financial services and other sectors of the economic system. We've got to maintain that equilibrium correct."

The Treasury chief also stated she was cooperating with international partners "regarding our own critical minerals plan, so that we are more independent."

NHS Drug Costs and Funding

The Chancellor also admitted that the price the National Health Service spends on medicines could increase as a consequence of ongoing negotiations with the Trump administration and its drugs companies, in return for lower tariffs and capital.

A number of the biggest global drug companies have said lately that they are either pausing or scrapping operations in the United Kingdom, with some blaming the modest returns they are receiving.

Recently, the government science advisor said the price the NHS pays for medicines would have to go up to stop companies and drug research funding departing from the UK.

Reeves told media: "It has been observed due to the payment system, that drug testing, innovative medicines have not been offered in the UK in the manner that they are in other continental states."

"The objective is to ensure that individuals getting treatment from the NHS are able to access the top essential drugs in the globe. And so we are reviewing all of that, and... aiming to attract additional funding into the UK."